Stoke Therapeutics, Inc. (STOK)
31.93
-0.47
(-1.45%)
USD |
NASDAQ |
Feb 09, 16:00
31.93
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics EPS Diluted (Quarterly) : -0.6543 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Insmed, Inc. | -1.747 |
| Pfizer Inc. | -0.2898 |
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.35M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 48.98M |
| Enterprise Value | 1.607B |
| Gross Profit Margin (Quarterly) | 90.70% |
| Profit Margin (Quarterly) | -360.7% |
| Earnings Yield | 2.07% |
| Operating Earnings Yield | 1.46% |
| Normalized Earnings Yield | 2.067 |